Skip to Main Content

Paper Details

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol
3
2023
Author NameAffiliation
Steven GallingerPrincess Margaret Hospital, Toronto National Cancer Institute of Canada Clinical Trials Group, Ontario Cross Cancer Institute, KY university of california los angeles Medical Center, CA M. D. Anderson Cancer Centre, TX OSI Pharmaceuticals, CO Sourasky Medical Centre, Poland Confidence Medical Centre, Argentina and the National University Hospital
Keyue DingPrincess Margaret Hospital, Toronto National Cancer Institute of Canada Clinical Trials Group, Ontario Cross Cancer Institute, KY university of california los angeles Medical Center, CA M. D. Anderson Cancer Centre, TX OSI Pharmaceuticals, CO Sourasky Medical Centre, Poland Confidence Medical Centre, Argentina and the National University Hospital
  • 1 - 2

Datasets